| Gerald Robbin Fisher, PHARMD | |
|
3333 Grand Ave, Billings, MT 59102-6565 | |
| (406) 652-1620 | |
| Not Available |
| Full Name | Gerald Robbin Fisher |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3333 Grand Ave, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023667771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P8444 (Idaho) | Secondary |
| 183500000X | Pharmacist | PHA-PHA-LIC-63309 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gerald Robbin Fisher, PHARMD 3333 Grand Ave, Billings, MT 59102-6565 Ph: () - | Gerald Robbin Fisher, PHARMD 3333 Grand Ave, Billings, MT 59102-6565 Ph: (406) 652-1620 |
News Archive
Although there's "increasing pressure" on President Obama "to fill his administration's vacant top foreign-assistance post ... no candidate is in sight nine months into his term," the Associated Press writes in an article exploring the absence of a leader for USAID. Obama and Secretary of State Hillary Rodham Clinton have expressed a desire for "the agency to play a bigger role in U.S. foreign policy ... [with] more equal roles for diplomacy and development alongside defense," according to the AP.
MUSC Hollings Cancer Center researchers identified that blocking an alternative energy pathway for T-cells after hematopoietic stem cell transplant helps reduce graft-versus-host disease (GVHD) in an animal model of leukemia.
Using pseudoviruses with single amino acid substitutions, researchers found that mutations in SARS-CoV-2 reduce monoclonal antibody neutralization differently. However, convalescent sera samples did not lose neutralization potency many and were also effective against the B.1.1.7 (UK-derived) strain.
Ranbaxy Laboratories Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), today announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, a novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne.
Outcome Sciences, Inc., the leading provider of patient registries, studies, and technologies for evaluating real-world outcomes, today announced that its TotalQuality Reporting Service has become a certified electronic health records technology reporting module for the Centers for Medicare and Medicaid's Meaningful Use data submission.
› Verified 1 days ago
Hannah Elizabeth Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1649 Main St, Billings, MT 59105 Phone: 406-254-2842 | |
David Sanks, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2525 King Ave W, Billings, MT 59102 Phone: 406-652-9688 | |
Joshua Teynor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1602 Main St, Billings, MT 59105 Phone: 406-245-0178 | |
Dr. Natalie Marie Waterfall, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 670 Main St, Billings, MT 59105 Phone: 406-245-6979 | |
Barbara Metzger, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2290 King Ave W, Billings, MT 59102 Phone: 406-656-8556 | |
Kailey Klinger, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1775 Spring Creek Lane, Billings, MT 59102 Phone: 406-373-3500 Fax: 406-373-3607 |